Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read General business news Ascend Performance Materials to emerge from Chapter 11 with stronger balance sheet and growth focus Ascend Performance Materials secures court approval to exit Chapter 11 with a leaner balance sheet and renewed growth plan. Find out what comes next. bySrinathDecember 10, 2025